S&P 500   3,150.29 (+1.05%)
DOW   28,024.05 (+1.25%)
QQQ   205.03 (+1.28%)
AAPL   270.78 (+1.96%)
FB   200.93 (+0.79%)
MSFT   151.37 (+0.96%)
GOOGL   1,340.74 (+1.65%)
AMZN   1,752.17 (-0.48%)
CGC   18.66 (+0.32%)
NVDA   211.65 (+1.06%)
MU   48.02 (+3.00%)
BABA   201.66 (+0.83%)
GE   10.98 (+1.76%)
TSLA   337.34 (+1.29%)
T   38.29 (+0.26%)
AMD   39.59 (-0.25%)
NFLX   306.25 (+0.63%)
DIS   147.94 (+0.34%)
S&P 500   3,150.29 (+1.05%)
DOW   28,024.05 (+1.25%)
QQQ   205.03 (+1.28%)
AAPL   270.78 (+1.96%)
FB   200.93 (+0.79%)
MSFT   151.37 (+0.96%)
GOOGL   1,340.74 (+1.65%)
AMZN   1,752.17 (-0.48%)
CGC   18.66 (+0.32%)
NVDA   211.65 (+1.06%)
MU   48.02 (+3.00%)
BABA   201.66 (+0.83%)
GE   10.98 (+1.76%)
TSLA   337.34 (+1.29%)
T   38.29 (+0.26%)
AMD   39.59 (-0.25%)
NFLX   306.25 (+0.63%)
DIS   147.94 (+0.34%)
S&P 500   3,150.29 (+1.05%)
DOW   28,024.05 (+1.25%)
QQQ   205.03 (+1.28%)
AAPL   270.78 (+1.96%)
FB   200.93 (+0.79%)
MSFT   151.37 (+0.96%)
GOOGL   1,340.74 (+1.65%)
AMZN   1,752.17 (-0.48%)
CGC   18.66 (+0.32%)
NVDA   211.65 (+1.06%)
MU   48.02 (+3.00%)
BABA   201.66 (+0.83%)
GE   10.98 (+1.76%)
TSLA   337.34 (+1.29%)
T   38.29 (+0.26%)
AMD   39.59 (-0.25%)
NFLX   306.25 (+0.63%)
DIS   147.94 (+0.34%)
S&P 500   3,150.29 (+1.05%)
DOW   28,024.05 (+1.25%)
QQQ   205.03 (+1.28%)
AAPL   270.78 (+1.96%)
FB   200.93 (+0.79%)
MSFT   151.37 (+0.96%)
GOOGL   1,340.74 (+1.65%)
AMZN   1,752.17 (-0.48%)
CGC   18.66 (+0.32%)
NVDA   211.65 (+1.06%)
MU   48.02 (+3.00%)
BABA   201.66 (+0.83%)
GE   10.98 (+1.76%)
TSLA   337.34 (+1.29%)
T   38.29 (+0.26%)
AMD   39.59 (-0.25%)
NFLX   306.25 (+0.63%)
DIS   147.94 (+0.34%)
Log in

NASDAQ:SRRK - Scholar Rock Stock Price, Forecast & News

$8.60
+0.61 (+7.63 %)
(As of 12/6/2019 01:20 PM ET)
Today's Range
$7.91
Now: $8.60
$8.60
50-Day Range
$7.20
MA: $8.97
$10.58
52-Week Range
$6.95
Now: $8.60
$30.00
Volume2,431 shs
Average Volume102,913 shs
Market Capitalization$255.23 million
P/E RatioN/A
Dividend YieldN/A
Beta0.02
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its lead antibody product candidate is SRK-015, an inhibitor of the activation of myostatin, which is in Phase I clinical trials for the treatment of spinal muscular atrophy. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SRRK
CUSIPN/A
CIKN/A
Phone857-259-3860

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$380,000.00
Book Value$4.22 per share

Profitability

Net Income$-49,330,000.00

Miscellaneous

Employees65
Market Cap$255.23 million
Next Earnings Date3/16/2020 (Estimated)
OptionableNot Optionable

Receive SRRK News and Ratings via Email

Sign-up to receive the latest news and ratings for SRRK and its competitors with MarketBeat's FREE daily newsletter.


Scholar Rock (NASDAQ:SRRK) Frequently Asked Questions

What is Scholar Rock's stock symbol?

Scholar Rock trades on the NASDAQ under the ticker symbol "SRRK."

How were Scholar Rock's earnings last quarter?

Scholar Rock Holding Corp (NASDAQ:SRRK) issued its earnings results on Tuesday, November, 12th. The company reported ($0.55) earnings per share for the quarter, missing the consensus estimate of ($0.33) by $0.22. The company had revenue of $4.77 million for the quarter, compared to the consensus estimate of $12.73 million. View Scholar Rock's Earnings History.

When is Scholar Rock's next earnings date?

Scholar Rock is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Scholar Rock.

What price target have analysts set for SRRK?

2 brokers have issued 12 month target prices for Scholar Rock's shares. Their forecasts range from $27.00 to $27.00. On average, they expect Scholar Rock's stock price to reach $27.00 in the next twelve months. This suggests a possible upside of 214.0% from the stock's current price. View Analyst Price Targets for Scholar Rock.

What is the consensus analysts' recommendation for Scholar Rock?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Scholar Rock in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Scholar Rock.

Has Scholar Rock been receiving favorable news coverage?

Headlines about SRRK stock have trended neutral on Friday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Scholar Rock earned a coverage optimism score of 0.4 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Scholar Rock.

Who are some of Scholar Rock's key competitors?

What other stocks do shareholders of Scholar Rock own?

Who are Scholar Rock's key executives?

Scholar Rock's management team includes the folowing people:
  • Mr. Nagesh K. Mahanthappa Ph.D., Pres, CEO & Exec. Director (Age 54)
  • Mr. Yung H. Chyung, Chief Medical Officer (Age 43)
  • Ms. Rhonda M. Chicko, Chief Financial Officer (Age 53)
  • Mr. Alan J. Buckler, Chief Scientific Officer (Age 59)
  • Ms. Catherine Hu, Exec. Director of Investor Relations & Corp. Communications

When did Scholar Rock IPO?

(SRRK) raised $76 million in an initial public offering (IPO) on Thursday, May 24th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. Jefferies, Cowen and BMO Capital Markets acted as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Who are Scholar Rock's major shareholders?

Scholar Rock's stock is owned by a number of of retail and institutional investors. Top institutional investors include Redmile Group LLC (9.63%), State Street Corp (1.09%), Squarepoint Ops LLC (0.27%), Alps Advisors Inc. (0.20%), Millennium Management LLC (0.14%) and Alberta Investment Management Corp (0.13%). Company insiders that own Scholar Rock stock include Amir Nashat and International SCA Artal. View Institutional Ownership Trends for Scholar Rock.

Which major investors are selling Scholar Rock stock?

SRRK stock was sold by a variety of institutional investors in the last quarter, including Redmile Group LLC and Barclays PLC. View Insider Buying and Selling for Scholar Rock.

Which major investors are buying Scholar Rock stock?

SRRK stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Millennium Management LLC, Alberta Investment Management Corp, Bowling Portfolio Management LLC, Squarepoint Ops LLC, Public Employees Retirement System of Ohio, Russell Investments Group Ltd. and Alps Advisors Inc.. Company insiders that have bought Scholar Rock stock in the last two years include Amir Nashat and International SCA Artal. View Insider Buying and Selling for Scholar Rock.

How do I buy shares of Scholar Rock?

Shares of SRRK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Scholar Rock's stock price today?

One share of SRRK stock can currently be purchased for approximately $8.60.

How big of a company is Scholar Rock?

Scholar Rock has a market capitalization of $255.23 million and generates $380,000.00 in revenue each year. The company earns $-49,330,000.00 in net income (profit) each year or ($3.15) on an earnings per share basis. Scholar Rock employs 65 workers across the globe.View Additional Information About Scholar Rock.

What is Scholar Rock's official website?

The official website for Scholar Rock is http://www.scholarrock.com/.

How can I contact Scholar Rock?

Scholar Rock's mailing address is 620 MEMORIAL DRIVE 2ND FLOOR, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-259-3860 or via email at [email protected]


MarketBeat Community Rating for Scholar Rock (NASDAQ SRRK)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  102 (Vote Outperform)
Underperform Votes:  125 (Vote Underperform)
Total Votes:  227
MarketBeat's community ratings are surveys of what our community members think about Scholar Rock and other stocks. Vote "Outperform" if you believe SRRK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRRK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel